J Clin Invest. 2024 Jun 3;134(11):e181137. doi: 10.1172/JCI181137.
Although antibody-mediated lung damage is a major factor in transfusion-related acute lung injury (ALI), autoimmune lung disease (for example, coatomer subunit α [COPA] syndrome), and primary graft dysfunction following lung transplantation, the mechanism by which antigen-antibody complexes activate complement to induce lung damage remains unclear. In this issue of the JCI, Cleary and colleagues utilized several approaches to demonstrate that IgG forms hexamers with MHC class I alloantibodies. This hexamerization served as a key pathophysiological mechanism in alloimmune lung injury models and was mediated through the classical pathway of complement activation. Additionally, the authors provided avenues for exploring therapeutics for this currently hard-to-treat clinical entity that has several etiologies but a potentially focused mechanism.
虽然抗体介导的肺部损伤是输血相关急性肺损伤(ALI)、自身免疫性肺部疾病(例如,COP 亚基α[COPA]综合征)和肺移植后原发性移植物功能障碍的主要因素,但抗原抗体复合物激活补体诱导肺部损伤的机制仍不清楚。在本期 JCI 中,Cleary 及其同事利用多种方法证明 IgG 与 MHC Ⅰ类同种抗体形成六聚体。这种六聚化是同种免疫性肺损伤模型中的关键病理生理机制,通过补体激活的经典途径介导。此外,作者还为探索针对这一目前难以治疗的临床实体的治疗方法提供了途径,该实体有多种病因,但潜在的机制可能较为集中。